Client Projects (Vaccines)
Various Infectious Diseases
Preclinical through CommercialActive
Key Facts
Indication
Various Infectious Diseases
Phase
Preclinical through Commercial
Status
Active
Company
About IDT Biologika
IDT Biologika is a century-old, privately-held German CDMO with a strong focus on complex biologics, particularly live virus products and viral vectors. It operates as a full-service partner offering end-to-end solutions from process development to commercial-scale drug substance manufacturing and aseptic fill-finish across two BSL-2 certified sites. With significant regulatory approvals (EMA, FDA) and over €600 million invested in its facilities since 1993, the company is positioned as a key player in the growing outsourced manufacturing market for vaccines and advanced therapies. Its deep historical expertise in virology provides a distinct competitive advantage in the cell and gene therapy space.
View full company profileTherapeutic Areas
Other Various Infectious Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Hyperimmune Globulins | Kedrion Biopharma | Development |
| Infectious Disease Serology Portfolio Expansion | GenBio | Commercial/Development |
| Partnership-based Vaccine Development & Manufacturing | Bilthoven Biologicals | Varies by Partner |
| Platform Partnerships (e.g., with Merck) | Vaxxas | Pre-clinical/Phase 1 |
| Infectious Disease Assay Development | CD Diagnostics | Development/Validation |